Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motomu Hashimoto

Showing results (91-100 of 221) with videos related to

Pageof 23
Sort By:
Arthritis Research & Therapy|January 3, 2024
Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritisTakeshi Iwasaki, Ryu Watanabe, Hiromu Ito, et al.
Modern Rheumatology|April 4, 2020
Severe joint deformity and patient global assessment of disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patientsShuichiro Nakabo, Yuko Tsuji, Maiko Inagaki, et al.
Advances in Rheumatology (London, England)|October 30, 2021
Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional studyMiyabi Uda, Motomu Hashimoto, Ryuji Uozumi, et al.
Arthritis Research & Therapy|July 10, 2025
Roles of JAK-STAT signaling and granulocyte-macrophage colony-stimulating factor in the development of osteitis and bone microstructure changes in rheumatoid arthritisTsuneyasu Yoshida, Yoshiki Murotani, Koichi Murata, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 17, 2016
Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathySumie Hiramatsu, Koichiro Ohmura, Hideaki Tsuji, et al.
Frontiers in Immunology|January 24, 2022
ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic DermatomyositisTakashi Matsuo, Tsuneo Sasai, Ran Nakashima, et al.
Rheumatology International|April 27, 2021
Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective studyYuichi Maeda, Toru Hirano, Kosuke Ebina, et al.
Arthritis Research & Therapy|January 9, 2024
Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohortTakayuki Fujii, Koichi Murata, Hideo Onizawa, et al.
Modern Rheumatology|August 10, 2018
Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritisMie Torii, Motomu Hashimoto, Akiko Hanai, et al.
Arthritis Research & Therapy|April 16, 2021
Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort studySadao Jinno, Akira Onishi, Maureen Dubreuil, et al.
Pageof 23

Showing results (91-100 of 221) with videos related to

Sort By:
Pageof 23
Arthritis Research & Therapy|January 3, 2024
Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritisTakeshi Iwasaki, Ryu Watanabe, Hiromu Ito, et al.
Modern Rheumatology|April 4, 2020
Severe joint deformity and patient global assessment of disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patientsShuichiro Nakabo, Yuko Tsuji, Maiko Inagaki, et al.
Advances in Rheumatology (London, England)|October 30, 2021
Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional studyMiyabi Uda, Motomu Hashimoto, Ryuji Uozumi, et al.
Arthritis Research & Therapy|July 10, 2025
Roles of JAK-STAT signaling and granulocyte-macrophage colony-stimulating factor in the development of osteitis and bone microstructure changes in rheumatoid arthritisTsuneyasu Yoshida, Yoshiki Murotani, Koichi Murata, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 17, 2016
Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathySumie Hiramatsu, Koichiro Ohmura, Hideaki Tsuji, et al.
Frontiers in Immunology|January 24, 2022
ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic DermatomyositisTakashi Matsuo, Tsuneo Sasai, Ran Nakashima, et al.
Rheumatology International|April 27, 2021
Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective studyYuichi Maeda, Toru Hirano, Kosuke Ebina, et al.
Arthritis Research & Therapy|January 9, 2024
Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohortTakayuki Fujii, Koichi Murata, Hideo Onizawa, et al.
Modern Rheumatology|August 10, 2018
Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritisMie Torii, Motomu Hashimoto, Akiko Hanai, et al.
Arthritis Research & Therapy|April 16, 2021
Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort studySadao Jinno, Akira Onishi, Maureen Dubreuil, et al.
Pageof 23